Bleeding complications in the patient with cardiac disease following thrombolytic and anticoagulant therapies.
Thrombolytic and anticoagulant therapies are used frequently in the cardiac patient. Bleeding complications and other coagulation defects, such as heparin-induced thrombocytopenia (HITP), can occur following the administration of these drugs. Nurses caring for the cardiac patient need to be aware of the potential for bleeding and know how to safely and effectively care for the patient who experiences a bleeding event.
Dunn
S M
SM
Senerchia
C B
CB
D000925:Anticoagulants / Q000009:adverse effects*; D003422:Critical Care; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006331:Heart Diseases / Q000188:drug therapy*; D006470:Hemorrhage / Q000139:chemically induced* / Q000451:nursing / Q000628:therapy; D006801:Humans
D000925:Anticoagulants; D005343:Fibrinolytic Agents